Quantitative mass spectrometry imaging (qMSI) enables spatially resolved metabolite profiling in biological tissues, yet reliable concentration mapping remains constrained by high matrix-derived background interference, limited metabolite coverage, and insufficient calibration robustness. To overcome these challenges, a single-atom platinum-anchored molybdenum oxide matrix (denoted as Ptsa/MoOx) was developed for qMSI. Compared with conventional organic matrices, the Ptsa/MoOx matrix not only substantially enhances metabolite ion signals but also effectively suppresses low-mass background interference. Comprehensive structural characterization revealed oxygen-deficient MoOx with highly dispersed Pt single atoms, and mechanistic investigation indicated that charge-mediated desorption and ionization contribute to the enhanced matrix performance. Using Ptsa/MoOx-assisted qMSI, an on-tissue calibration strategy was established across a wide polarity range of metabolites, achieving excellent linear responses from 43 to 853 ng mm−2. For metabolites lacking authentic standards, a class-matched concentration-referencing strategy was applied to generate concentration-referenced spatial maps for 124 metabolites. Application to five paired pancreatic tumor and adjacent non-tumor specimens demonstrated region-dependent differences across multiple lipid-related pathways as a proof-of-concept tissue application. Collectively, these results establish Ptsa/MoOx-assisted qMSI as an on-tissue calibrated platform for spatial metabolomics and demonstrate its potential for characterizing metabolic heterogeneity in biological tissues.
No takes yet. Share an insight, caveat, or question.
Ning et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: